| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.5 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |